Tudor Investment Corp
TEVA icon

Tudor Investment Corp’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Tudor Investment Corp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6M Sell
490,000
-54,501
-10% -$1.82M 0.02% 572
2026
Q1 		$16.4M Buy
544,501
+44,501
+9% +$1.43M 0.03% 507
2025
Q4 		$15.6M Sell
500,000
-150,000
-23% -$3.7M 0.03% 510
2025
Q3 		$13.1M Hold
650,000
– – 0.02% 629
2025
Q2 		$10.9M Sell
650,000
-47,457
-7% -$766K 0.02% 618
2025
Q1 		$10.7M Buy
697,457
+247,456
+55% +$4.42M 0.04% 426
2024
Q4 		$9.92M Sell
450,001
-365,000
-45% -$6.64M 0.04% 362
2024
Q3 		$14.7M Sell
815,001
-40,000
-5% -$700K 0.05% 269
2024
Q2 		$13.9M Sell
855,001
-90,048
-10% -$1.39M 0.07% 272
2024
Q1 		$13.3M Sell
945,049
-11,288
-1% -$142K 0.08% 258
2023
Q4 		$9.98M Buy
956,337
+61,836
+7% +$577K 0.08% 344
2023
Q3 		$9.12M Buy
894,501
+208,776
+30% +$1.94M 0.09% 270
2023
Q2 		$5.16M Sell
685,725
-472,253
-41% -$3.83M 0.06% 412
2023
Q1 		$10.2M Buy
1,157,978
+11,859
+1% +$117K 0.16% 138
2022
Q4 		$10.5M Buy
1,146,119
+21,032
+2% +$184K 0.21% 76
2022
Q3 		$9.08M Buy
1,125,087
+10,000
+0.9% +$88.4K 0.2% 96
2022
Q2 		$8.38M Buy
1,115,087
+415,000
+59% +$3.62M 0.22% 66
2022
Q1 		$6.57M Buy
+700,087
New +$5.84M 0.15% 141
2020
Q4 		– Sell
-10,174
Closed -$92K – 1620
2020
Q3 		$92K Buy
+10,174
New +$108K ﹤0.01% 1190
2020
Q2 		– Sell
-10,100
Closed -$91K – 1413
2020
Q1 		$91K Sell
10,100
-496
-5% -$5.08K 0.01% 935
2019
Q4 		$104K Buy
+10,596
New +$94.6K ﹤0.01% 1050
2016
Q4 		– Sell
-5,930
Closed -$273K – 1605
2016
Q3 		$273K Buy
+5,930
New +$309K 0.01% 1089
2016
Q2 		– Sell
-10,782
Closed -$577K – 1919
2016
Q1 		$577K Sell
10,782
-389,218
-97% -$22.8M 0.01% 852
2015
Q4 		$26.3M Buy
400,000
+389,700
+3,783% +$24.1M 0.74% 23
2015
Q3 		$582K Sell
10,300
-389,700
-97% -$25.3M 0.02% 688
2015
Q2 		$23.6M Sell
400,000
-150,000
-27% -$9.25M 0.69% 28
2015
Q1 		$34.3M Buy
+550,000
New +$32M 1.1% 9
2014
Q2 		– Sell
-300,000
Closed -$15.9M – 1320
2014
Q1 		$15.9M Buy
+300,000
New +$13.9M 0.67% 31

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Tudor Investment Corp's TEVA Position: Q2 2026 in Review

Tudor Investment Corp reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 10% in Q2 2026, selling an estimated $1.82M and leaving 490,000 shares worth $16.6M. The position accounts for 0.02% of the portfolio, ranked #572.

Tudor Investment Corp first reported a position in TEVA in Q1 2014 and has held it in 28 quarters since. The position peaked at $34.3M in Q1 2015. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Tudor Investment Corp held 490,000 shares of Teva Pharmaceutical Industries Limited worth $16.6M as of Q2 2026.
  • Tudor Investment Corp sold 54,501 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $1.82M.
  • Teva Pharmaceutical Industries Limited made up 0.02% of Tudor Investment Corp's portfolio in Q2 2026, its #572 holding.
  • Tudor Investment Corp first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and has held it in 28 quarters since.
  • Tudor Investment Corp's Teva Pharmaceutical Industries Limited position peaked at $34.3M in Q1 2015.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.